128 related articles for article (PubMed ID: 29970675)
1. Triptolide: A new star for treating human malignancies.
Yan P; Sun X
J Cancer Res Ther; 2018 Jun; 14(Supplement):S271-S275. PubMed ID: 29970675
[TBL] [Abstract][Full Text] [Related]
2. The main anticancer bullets of the Chinese medicinal herb, thunder god vine.
Liu Z; Ma L; Zhou GB
Molecules; 2011 Jun; 16(6):5283-97. PubMed ID: 21701438
[TBL] [Abstract][Full Text] [Related]
3. Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation.
He QL; Minn I; Wang Q; Xu P; Head SA; Datan E; Yu B; Pomper MG; Liu JO
Angew Chem Int Ed Engl; 2016 Sep; 55(39):12035-9. PubMed ID: 27574181
[TBL] [Abstract][Full Text] [Related]
4. Triptolide Inhibits Lung Cancer Cell Migration, Invasion, and Metastasis.
Reno TA; Kim JY; Raz DJ
Ann Thorac Surg; 2015 Nov; 100(5):1817-24; discussion 1824-5. PubMed ID: 26298168
[TBL] [Abstract][Full Text] [Related]
5. Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3 epsilon.
Liu Y; Song F; Wu WK; He M; Zhao L; Sun X; Li H; Jiang Y; Yang Y; Peng K
Cell Biochem Funct; 2012 Jun; 30(4):271-8. PubMed ID: 22315045
[TBL] [Abstract][Full Text] [Related]
6. Pancreas cancer meets the thunder god.
Hingorani SR; Potter JD
Sci Transl Med; 2012 Oct; 4(156):156ps21. PubMed ID: 23076355
[TBL] [Abstract][Full Text] [Related]
7. Enhanced anti-tumor activity of triptolide in combination with irradiation for the treatment of oral cancer.
Chen YW; Lin GJ; Hueng DY; Huang SH; Chia WT; Shieh YS; Ma KH; Sytwu HK
Planta Med; 2014 Mar; 80(4):255-61. PubMed ID: 24510366
[TBL] [Abstract][Full Text] [Related]
8. Triptolide alters histone H3K9 and H3K27 methylation state and induces G0/G1 arrest and caspase-dependent apoptosis in multiple myeloma in vitro.
Zhao F; Chen Y; Li R; Liu Y; Wen L; Zhang C
Toxicology; 2010 Jan; 267(1-3):70-9. PubMed ID: 19879315
[TBL] [Abstract][Full Text] [Related]
9. [Advance in the anti-tumor mechanism of triptolide].
Luo Y; Shi C; Liao M
Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(16):2024-6. PubMed ID: 19938536
[TBL] [Abstract][Full Text] [Related]
10. Triptolide with potential medicinal value for diseases of the central nervous system.
Zheng Y; Zhang WJ; Wang XM
CNS Neurosci Ther; 2013 Feb; 19(2):76-82. PubMed ID: 23253124
[TBL] [Abstract][Full Text] [Related]
11. Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo.
Antonoff MB; Chugh R; Borja-Cacho D; Dudeja V; Clawson KA; Skube SJ; Sorenson BS; Saltzman DA; Vickers SM; Saluja AK
Surgery; 2009 Aug; 146(2):282-90. PubMed ID: 19628086
[TBL] [Abstract][Full Text] [Related]
12. Minnelide, a novel drug for pancreatic and liver cancer.
Banerjee S; Saluja A
Pancreatology; 2015 Jul; 15(4 Suppl):S39-43. PubMed ID: 26122306
[TBL] [Abstract][Full Text] [Related]
13. Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.
Kim ST; Kim SY; Lee J; Kim K; Park SH; Park YS; Lim HY; Kang WK; Park JO
BMC Cancer; 2018 Nov; 18(1):1103. PubMed ID: 30419860
[TBL] [Abstract][Full Text] [Related]
14. Primary and liver metastasis-derived cell lines from KrasG12D; Trp53R172H; Pdx-1 Cre animals undergo apoptosis in response to triptolide.
Sangwan V; Banerjee S; Jensen KM; Chen Z; Chugh R; Dudeja V; Vickers SM; Saluja AK
Pancreas; 2015 May; 44(4):583-9. PubMed ID: 25875797
[TBL] [Abstract][Full Text] [Related]
15. Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies.
Zang Y; Lai F; Fu J; Li C; Ma J; Chen C; Liu K; Zhang T; Chen X; Zhang D
Eur J Med Chem; 2020 Mar; 190():112079. PubMed ID: 32028140
[TBL] [Abstract][Full Text] [Related]
16. Triptolide and Its Derivatives as Cancer Therapies.
Noel P; Von Hoff DD; Saluja AK; Velagapudi M; Borazanci E; Han H
Trends Pharmacol Sci; 2019 May; 40(5):327-341. PubMed ID: 30975442
[TBL] [Abstract][Full Text] [Related]
17. Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180.
Lin Y; Yang X; Lu M; Zheng W; Zhang J; Zhuang H; Hua ZC
Anticancer Drugs; 2013 Oct; 24(9):945-57. PubMed ID: 23958791
[TBL] [Abstract][Full Text] [Related]
18. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
19. Triptolide and management of systemic malignancies besides pancreatic carcinomas.
Kapoor S
World J Gastroenterol; 2009 Feb; 15(8):1018-9. PubMed ID: 19248206
[TBL] [Abstract][Full Text] [Related]
20. The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer.
Reno TA; Tong SW; Wu J; Fidler JM; Nelson R; Kim JY; Raz DJ
BMC Cancer; 2016 Jul; 16():439. PubMed ID: 27400883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
